Directing transition from innate to acquired immunity defining a role for IL-6

被引:595
作者
Jones, SA [1 ]
机构
[1] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, Wales
基金
英国惠康基金;
关键词
D O I
10.4049/jimmunol.175.6.3463
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Appropriate control of leukocyte recruitment and activation is a fundamental requirement for competent host defense and resolving inflammation. A pivotalevent that defines the successful outcome of any inflammatory event is the transition from innate to acquired immunity. In IL-6 deficiency, this process appears defective, and a series of in vivo studies have documented important roles for IL-6 in both the resolution of innate immunity and the development of acquired immune responses. Within this review, particular attention will be given to the regulatory properties of the soluble IL-6 receptor and how its activity may affect chronic disease progression.
引用
收藏
页码:3463 / 3468
页数:6
相关论文
共 71 条
  • [1] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
    Atreya, R
    Mudter, J
    Finotto, S
    Müllberg, J
    Jostock, T
    Wirtz, S
    Schütz, M
    Bartsch, B
    Holtmann, M
    Becker, C
    Strand, D
    Czaja, J
    Schlaak, JF
    Lehr, HA
    Autschbach, F
    Schürmann, G
    Nishimoto, N
    Yoshizaki, K
    Ito, H
    Kishimoto, T
    Galle, PR
    Rose-John, S
    Neurath, MF
    [J]. NATURE MEDICINE, 2000, 6 (05) : 583 - 588
  • [2] A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis
    Atsumi, T
    Ishihara, K
    Kamimura, D
    Ikushima, H
    Ohtani, T
    Hirota, S
    Kobayashi, H
    Park, SJ
    Saeki, Y
    Kitamura, Y
    Hirano, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) : 979 - 990
  • [3] PROTECTIVE ROLE OF INTERLEUKIN-6 IN THE LIPOPOLYSACCHARIDE-GALACTOSAMINE SEPTIC SHOCK MODEL
    BARTON, BE
    JACKSON, JV
    [J]. INFECTION AND IMMUNITY, 1993, 61 (04) : 1496 - 1499
  • [4] TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
    Becker, C
    Fantini, MC
    Schramm, C
    Lehr, HA
    Wirtz, S
    Nikolaev, A
    Burg, J
    Strand, S
    Kiesslich, R
    Huber, S
    Ito, H
    Nishimoto, N
    Yoshizaki, K
    Nishimoto, N
    Galle, PR
    Blessing, M
    Rose-John, S
    Neurath, MF
    [J]. IMMUNITY, 2004, 21 (04) : 491 - 501
  • [5] Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow
    Bleier, JI
    Pillarisetty, VG
    Shah, AB
    DeMatteo, RP
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (12) : 7408 - 7416
  • [6] Chen CK, 2004, ASIAN J CONTROL, V6, P130, DOI 10.1111/j.1934-6093.2004.tb00191.x
  • [7] IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
    Chomarat, P
    Banchereau, J
    Davoust, J
    Palucka, AK
    [J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 510 - 514
  • [8] Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis - A randomized, double-blind, placebo-controlled, dose-escalation trial
    Choy, EHS
    Isenberg, DA
    Garrood, T
    Farrow, S
    Ioannou, Y
    Bird, H
    Cheung, N
    Williams, B
    Hazleman, B
    Price, R
    Yoshizaki, K
    Nishimoto, N
    Kishimoto, T
    Panayi, GS
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3143 - 3150
  • [9] Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling
    Curnow, SJ
    Scheel-Toellner, D
    Jenkinson, W
    Raza, K
    Durrani, OM
    Faint, JM
    Rauz, S
    Wloka, K
    Pilling, D
    Rose-John, S
    Buckley, CD
    Murray, PI
    Salmon, M
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (08) : 5290 - 5297
  • [10] Desgeorges A, 1997, J RHEUMATOL, V24, P1510